The contractor shall determine the in vitro minimal inhibitory concentration (MIC) of candidate products against a panel of neisseria gonorrhoeae isolates.
Ended Awarded Last action
- Contract number
- 75N93023F00003
- Awardee
-
Element Materials Technology Iowa City Inc. UEI GAJDDSFFPD89
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $94,325
Award facts
- Contract value 49% obligated
-
- $94,325.00 Current, with exercised options
- $193,325.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- North Liberty, IA 52317, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $39,600 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $54,725 |
About this award
Element Materials Technology Iowa City Inc., operating as JMI Laboratories, was awarded a delivery order valued at $193,325 by the National Institute of Allergy and Infectious Diseases (NIAID) on August 31, 2023. The contract, which will be completed by August 30, 2024, requires the contractor to determine the in vitro minimal inhibitory concentration (MIC) of candidate products against a panel of Neisseria gonorrhoeae isolates. This delivery order was issued under the In Vitro Assessments of Antimicrobial Activity (IVAAA) indefinite-delivery/indefinite-quantity contract vehicle, a NIAID program focused on supporting antimicrobial resistance research. The work will be performed in North Liberty, Iowa. No small business set-aside was designated for this award.
JMI Laboratories is a microbiology specialist company with extensive expertise in antimicrobial resistance testing and in vitro assessments of antimicrobial activity. The company regularly conducts MIC assays and provides drug screening services supporting federal public health initiatives, particularly for the Department of Health and Human Services agencies including the FDA and National Institutes of Health. The firm-fixed-price delivery order represents a continuation of JMI Laboratories' ongoing work under the IVAAA vehicle, through which it has provided critical support to federal agencies addressing antimicrobial resistance challenges across multiple bacterial pathogens.
Quick answers
Who was awarded contract 75N93023F00003?
75N93023F00003 was awarded to Element Materials Technology Iowa City Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 31, 2023.
How much is contract 75N93023F00003 worth?
The government has obligated $94,325 on 75N93023F00003. Its potential value, with all options, is $193,325.
Is contract 75N93023F00003 an order under another contract?
Yes. 75N93023F00003 is a delivery order under 75N93019D00011, an indefinite delivery contract, on In Vitro Assessments of Antimicrobial Activity (IVAAA).
Was contract 75N93023F00003 competed?
The extent of competition for 75N93023F00003 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award